PARP Inhibition, a New Therapeutic Avenue in Patients with Prostate Cancer.
Flippot R, Patrikidou A, Aldea M, Colomba E, Lavaud P, Albigès L, Naoun N, Blanchard P, Terlizzi M, Garcia C, Bernard-Tessier A, Fuerea A, Di Palma M, Escudier B, Loriot Y, Baciarello G, Fizazi K.
Flippot R, et al. Among authors: patrikidou a.
Drugs. 2022 May;82(7):719-733. doi: 10.1007/s40265-022-01703-5. Epub 2022 May 5.
Drugs. 2022.
PMID: 35511402
Review.